Breast Cancer Products

Through the research and development of additional hormonal approaches to breast cancer treatment, represented by ARIMIDEX and FASLODEX, AstraZeneca has helped provide care for patients with breast cancer across the continuum. Learn more about our products for breast cancer treatment:

ARIMIDEX is indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer.

Learn more about ARIMIDEX.

Or visit the ARIMIDEX Professional Web site

 

FASLODEX is indicated for the treatment of hormone receptor-positive breast cancer in postmenopausal women with disease progression following antiestrogen therapy.

Learn more about FASLODEX.

Or visit the FASLODEX Professional Web site

 

Enroll in Hormonal Aspects of Breast Cancer Treatment,an online lecture series led by nationally recognized breast cancer experts who will share current information related to the management and hormonal treatment of breast cancer patients.

Next: ARIMIDEX